Quick Answer
BioAge Labs, Inc. reported Operating Income of -$92.78 million for fiscal year 2025.
BioAge Labs, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$92.78M | -18.7% |
| 2024 | -$78.19M | -61.6% |
| 2023 | -$48.40M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$23.14M | +6.5% | +6.6% |
| June 30, 2025 | -$24.77M | -62.2% | -50.6% |
| March 31, 2025 | -$16.45M | -28.4% | +33.6% |
| September 30, 2024 | -$24.75M | -150.3% | -62.1% |
| June 30, 2024 | -$15.27M | — | -19.2% |
| March 31, 2024 | -$12.81M | — | -29.6% |
| September 30, 2023 | -$9.89M | — | — |
- BioAge Labs, Inc. showed a decrease of -18.7% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, BioAge Labs, Inc.’s operating income has declined by 91.7% (from -$48.40 million to -$92.78 million).
- The most recent figure is from BioAge Labs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: